Supported by

For more than 20 years, Illumina has aspired to improve human health by unlocking the power of the genome. Our initial solutions enabled researchers to explore DNA in an entirely new way. We believe our technology will fundamentally change disease prevention, diagnosis, and treatment. While the rate of progress continues to accelerate exponentially as we move forward towards precision medicine, we have only just begun to discover the true impact of genomics. The discoveries we know lie ahead that will improve patient care are what inspire us to push the boundaries of our imagination and drive innovation.  

Learn more about Polygenic Risk Scores   PRS interview article

DOWNLOAD PRS FLYER